BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34111938)

  • 21. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Not Available].
    Bolotin S; Wilson S; Murti M
    CMAJ; 2021 Aug; 193(32):E1279-E1280. PubMed ID: 34400490
    [No Abstract]   [Full Text] [Related]  

  • 24. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health Care Workers Need COVID-19 Vaccination: Clinical, Public Health, and Ethical Considerations.
    Maki DG; Hennekens CH
    Am J Med; 2021 Dec; 134(12):1437-1439. PubMed ID: 34297977
    [No Abstract]   [Full Text] [Related]  

  • 26. Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications.
    Jung J
    J Korean Med Sci; 2021 Feb; 36(7):e59. PubMed ID: 33619920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Hot-spotting" to improve vaccine allocation by harnessing digital contact tracing technology: An application of percolation theory.
    Penney MD; Yargic Y; Smolin L; Thommes EW; Anand M; Bauch CT
    PLoS One; 2021; 16(9):e0256889. PubMed ID: 34551000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity.
    Blasi F; Gramegna A; Sotgiu G; Saderi L; Voza A; Aliberti S; Amati F
    Respir Med; 2021; 180():106355. PubMed ID: 33721697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccination for children: may be necessary for the full eradication of the disease.
    Praticò AD; Ruggieri M
    Pediatr Res; 2021 Dec; 90(6):1102-1103. PubMed ID: 34253861
    [No Abstract]   [Full Text] [Related]  

  • 32. Herd Immunity to COVID-19.
    Kadkhoda K
    Am J Clin Pathol; 2021 Mar; 155(4):471-472. PubMed ID: 33399182
    [No Abstract]   [Full Text] [Related]  

  • 33. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
    Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
    Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five reasons why COVID herd immunity is probably impossible.
    Aschwanden C
    Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are COVID vaccination programmes working? Scientists seek first clues.
    Mallapaty S
    Nature; 2021 Jan; 589(7843):504-505. PubMed ID: 33483685
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key populations for early COVID-19 immunization: preliminary guidance for policy.
    Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
    CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
    [No Abstract]   [Full Text] [Related]  

  • 39. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    Burckhardt RM; Dennehy JJ; Poon LLM; Saif LJ; Enquist LW
    J Virol; 2022 Feb; 96(3):e0197321. PubMed ID: 34817198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.